Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Spring Bank Pharmaceuticals revenue
Spring Bank Pharmaceuticals's revenue is $64.9 million.
What is Spring Bank Pharmaceuticals's revenue?
- Spring Bank Pharmaceuticals's revenue growth from 2009 to 2017 is 102.87%.
- Spring Bank Pharmaceuticals has 84 employees, and the revenue per employee ratio is $773,127.
- Spring Bank Pharmaceuticals's peak quarterly revenue was $21.0M in 2016(q4).
- Spring Bank Pharmaceuticals peak revenue was $64.9M in 2017.
- Spring Bank Pharmaceuticals annual revenue for 2016 was 56.5M, 18.06% growth from 2015.
- Spring Bank Pharmaceuticals annual revenue for 2017 was 64.9M, 15.02% growth from 2016.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Spring Bank Pharmaceuticals historical revenue
Spring Bank Pharmaceuticals's peak revenue was $64.9M in 2017. The peak quarterly revenue was $21.0M in 2016(q4).
Spring Bank Pharmaceuticals's revenue increased from $32.0m in 2009 to $64.9M currently. That's a 102.87% change in annual revenue.
Spring Bank Pharmaceuticals annual revenue
Spring Bank Pharmaceuticals annual revenue over time
| Fiscal year / year | Spring Bank Pharmaceuticals revenue |
|---|---|
| 2009 | $32.0M |
| 2010 | $33.5M |
| 2011 | $37.6M |
| 2012 | $33.1M |
| 2013 | $34.1M |
| 2014 | $37.9M |
| 2015 | $47.8M |
| 2016 | $56.5M |
| 2017 | $64.9M |
Rate Spring Bank Pharmaceuticals' financial transparency
Spring Bank Pharmaceuticals annual growth
Spring Bank Pharmaceuticals saw the greatest revenue growth in 2015, when revenue increased by 26.05%.
Spring Bank Pharmaceuticals had the lowest revenue growth in 2012, when revenue changed by -11.93%.
Spring Bank Pharmaceuticals annual growth rate over time
| Year | Spring Bank Pharmaceuticals growth |
|---|---|
| 2010 | 5%↑ |
| 2011 | 12%↑ |
| 2012 | -12%↓ |
| 2013 | 3%↑ |
| 2014 | 11%↑ |
| 2015 | 26%↑ |
| 2016 | 18%↑ |
| 2017 | 15%↑ |
Spring Bank Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Spring Bank Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2010 | - | - | - | $12.2M |
| 2011 | $7.9M | $8.4M | $10.1M | $11.1M |
| 2012 | $8.9M | $7.7M | $6.9M | $9.6M |
| 2013 | $8.2M | $8.1M | $8.3M | $9.4M |
| 2014 | $8.2M | $8.7M | $9.5M | $11.6M |
| 2015 | $11.5M | $14.1M | $11.9M | $10.4M |
| 2016 | $9.7M | $11.6M | $14.2M | $21.0M |
| 2017 | $17.1M | $13.9M | $17.2M | $16.7M |
| 2018 | $20.9M | $18.7M | $19.5M | - |
Spring Bank Pharmaceuticals jobs nearby
Do you work at Spring Bank Pharmaceuticals?
Did Spring Bank Pharmaceuticals meet its revenue projections?
Spring Bank Pharmaceuticals financial information
| CEO | Martin Driscoll |
| Company Type | Public |
| Employees Number | 84 |
| Date Founded | 2002 |
| Headquarters | Milford, Massachusetts |
| Number of Locations | 1 |
| Revenue | $64.9M |
| Net Income | $11,386,333 |
| Gross Proft | $25.3M (2017) |
| Tax Rate | 0.2% |
| Total Assets | $110,138,099 |
| Ticker | CYIG |
Spring Bank Pharmaceuticals jobs you might like
Spring Bank Pharmaceuticals financing
Spring Bank Pharmaceuticals received early financing of $3.9M on 2011-05-05.
| Series | Round size | Date |
|---|---|---|
| Grant | $3.9M | 05/2011 |
| Debt Financing | $4.2M | 01/2013 |
| Debt Financing | $6.3M | 02/2014 |
| Series Unknown | $11.6M | 01/2015 |
Spring Bank Pharmaceuticals investors
| Investors | Security type |
|---|---|
| National Institutes of Health (NIH) | Grant |
Spring Bank Pharmaceuticals competitors
Spring Bank Pharmaceuticals's top competitor, TRACON Pharmaceuticals, earned an annual revenue of $12.0M.
Spring Bank Pharmaceuticals's smallest competitor is Aditx Therapeutics with revenue of $80.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Prelude Therapeutics | - | $7.0M | 70 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Onconova Therapeutics | - | $226,000 | 12 | - |
| Aditx Therapeutics | - | $80,000 | 9 | - |
| Suono Bio | - | $1.0M | 30 | - |
| Avalon Pharmaceuticals | - | $3.4M | 50 | - |
| Constellation Pharmaceuticals | - | $4.7M | 82 | - |
| Treadwell Therapeutics | - | $860,000 | 17 | - |
| TRACON Pharmaceuticals | - | $12.0M | 36 | - |
| True REST | - | $1.5M | 63 | - |
Spring Bank Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Spring Bank Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Spring Bank Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Spring Bank Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Spring Bank Pharmaceuticals. The data presented on this page does not represent the view of Spring Bank Pharmaceuticals and its employees or that of Zippia.
Spring Bank Pharmaceuticals may also be known as or be related to Spring Bank Pharmaceuticals, Spring Bank Pharmaceuticals Inc and Spring Bank Pharmaceuticals, Inc.